1.05
price down icon2.78%   -0.03
after-market After Hours: 1.05
loading
Alx Oncology Holdings Inc stock is traded at $1.05, with a volume of 411.55K. It is down -2.78% in the last 24 hours and up +62.97% over the past month. ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
See More
Previous Close:
$1.08
Open:
$1.1
24h Volume:
411.55K
Relative Volume:
0.47
Market Cap:
$56.23M
Revenue:
-
Net Income/Loss:
$-151.16M
P/E Ratio:
-0.3535
EPS:
-2.97
Net Cash Flow:
$-130.08M
1W Performance:
-10.26%
1M Performance:
+62.97%
6M Performance:
+34.00%
1Y Performance:
-51.83%
1-Day Range:
Value
$1.05
$1.13
1-Week Range:
Value
$1.01
$1.27
52-Week Range:
Value
$0.404
$2.26

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Name
Name
Alx Oncology Holdings Inc
Name
Phone
650-466-7125
Name
Address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Name
Employee
49
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
ALXO's Discussions on Twitter

Compare ALXO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ALXO
Alx Oncology Holdings Inc
1.05 57.84M 0 -151.16M -130.08M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
387.15 100.34B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.50 60.95B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
451.73 60.46B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
734.35 46.04B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
332.20 36.02B 3.81B -644.79M -669.77M -6.24

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-06-25 Upgrade Jefferies Hold → Buy
Dec-19-24 Downgrade Jefferies Buy → Hold
Mar-08-24 Downgrade Stifel Buy → Hold
Dec-08-23 Upgrade Jefferies Hold → Buy
Dec-22-21 Downgrade Jefferies Buy → Hold
Sep-30-21 Initiated Stifel Buy
May-05-21 Resumed Credit Suisse Outperform
Apr-26-21 Resumed Credit Suisse Outperform
Apr-06-21 Initiated UBS Buy
Feb-10-21 Initiated H.C. Wainwright Buy
Aug-11-20 Initiated Cantor Fitzgerald Overweight
Aug-11-20 Initiated Credit Suisse Outperform
Aug-11-20 Initiated Jefferies Buy
Aug-11-20 Initiated Piper Sandler Overweight
View All

Alx Oncology Holdings Inc Stock (ALXO) Latest News

pulisher
Sep 17, 2025

Earnings Miss: Will ALX Oncology Holdings Inc stock hit new highs in YEARMarket Volume Summary & Safe Entry Trade Reports - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

What earnings revisions data tells us about ALX Oncology Holdings Inc.2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Merger Talk: Does TRIN have a sustainable dividendMarket Activity Summary & Free High Accuracy Swing Entry Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Evaluating ALX Oncology Holdings Inc. with trendline analysisQuarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com

Sep 17, 2025
pulisher
Sep 16, 2025

Published on: 2025-09-17 04:49:45 - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Will ALX Oncology Holdings Inc. rebound enough to break evenEarnings Overview Report & Consistent Return Strategy Ideas - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

ALX Oncology Announces Management Changes Amidst Nasdaq Compliance - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Is now a turning point for ALX Oncology Holdings Inc.Trade Risk Assessment & Daily Entry Point Trade Alerts - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

What to do if you’re stuck in ALX Oncology Holdings Inc.July 2025 News Drivers & High Accuracy Investment Signals - newser.com

Sep 16, 2025
pulisher
Sep 15, 2025

ALX Oncology Holdings Inc. stock retracement – recovery analysisMarket Sentiment Review & Entry Point Confirmation Signals - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

EPS Watch: What is the target price for Camp4 Therapeutics Corporation stockWeekly Trend Summary & Weekly Momentum Stock Picks - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Earnings Recap: Can ALX Oncology Holdings Inc reach all time highs this yearBond Market & Expert Curated Trade Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Patterns: Will ALX Oncology Holdings Inc benefit from government policyJuly 2025 Opening Moves & Target Return Focused Stock Picks - خودرو بانک

Sep 15, 2025
pulisher
Sep 14, 2025

How moving averages guide ALX Oncology Holdings Inc. tradingTrade Analysis Summary & Technical Confirmation Trade Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How to use a screener to detect ALX Oncology Holdings Inc. breakoutsJuly 2025 Update & High Yield Stock Recommendations - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How to recover losses in ALX Oncology Holdings Inc. stock2025 Risk Factors & Daily Stock Trend Watchlist - newser.com

Sep 14, 2025
pulisher
Sep 13, 2025

Can technical indicators confirm ALX Oncology Holdings Inc.’s reversal2025 Market Sentiment & Daily Stock Trend Reports - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

ALX Oncology appoints board member Klencke as interim CMO By Investing.com - Investing.com Nigeria

Sep 13, 2025
pulisher
Sep 12, 2025

How to escape a deep drawdown in ALX Oncology Holdings Inc.Weekly Trade Review & AI Driven Price Predictions - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Full technical analysis of ALX Oncology Holdings Inc. stockMarket Sentiment Summary & AI Forecast for Swing Trade Picks - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

ALX Oncology Holdings Inc. stock outlook for YEARMarket Activity Report & Technical Pattern Based Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Applying Elliott Wave Theory to ALX Oncology Holdings Inc.July 2025 Institutional & Safe Investment Capital Preservation Plans - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using Python tools to backtest ALX Oncology Holdings Inc. strategiesDividend Hike & Intraday High Probability Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using AI based signals to follow ALX Oncology Holdings Inc.Weekly Stock Summary & Verified Entry Point Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Will breakout in ALX Oncology Holdings Inc. lead to full recovery2025 Performance Recap & Entry Point Strategy Guides - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

ALX Oncology appoints board member Klencke as interim CMO - Investing.com

Sep 12, 2025
pulisher
Sep 12, 2025

Does ALX Oncology Holdings Inc. show high probability of rebound2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Long term hold vs stop loss in ALX Oncology Holdings Inc.Gap Down & Advanced Swing Trade Entry Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using economic indicators to assess ALX Oncology Holdings Inc. potentialMarket Weekly Review & AI Powered Market Entry Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

ALX Oncology Appoints Dr. Barbara Klencke as Interim Chief Medical Officer Following Departure of Dr. Alan Sandler - Quiver Quantitative

Sep 12, 2025
pulisher
Sep 12, 2025

ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer - GlobeNewswire

Sep 12, 2025
pulisher
Sep 12, 2025

30-Year Oncology Veteran Dr. Barbara Klencke Takes Helm as ALX Oncology's New Interim CMO - Stock Titan

Sep 12, 2025
pulisher
Sep 12, 2025

How to forecast ALX Oncology Holdings Inc. trends using time series2025 Sector Review & Accurate Entry/Exit Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Is ALX Oncology Holdings Inc. trending in predictive chart modelsEarnings Recap Summary & Real-Time Volume Analysis Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Published on: 2025-09-12 04:00:45 - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Does ALX Oncology Holdings Inc. fit your quant trading modelWeekly Market Summary & Weekly High Potential Stock Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Sector ETF performance correlation with ALX Oncology Holdings Inc.2025 Dividend Review & Technical Buy Zone Confirmation - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

What the charts say about ALX Oncology Holdings Inc. todayWeekly Investment Recap & Verified Stock Trade Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Strategies to average down on ALX Oncology Holdings Inc.Rate Hike & High Return Stock Watch Alerts - Newser

Sep 12, 2025
pulisher
Sep 11, 2025

Published on: 2025-09-11 19:28:20 - Newser

Sep 11, 2025

Alx Oncology Holdings Inc Stock (ALXO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$35.64
price up icon 0.62%
$84.80
price up icon 1.07%
$28.08
price down icon 0.57%
$98.15
price down icon 1.12%
$144.78
price up icon 0.02%
biotechnology ONC
$332.20
price up icon 1.53%
Cap:     |  Volume (24h):